Edwyn
Over the past five years, Becton, Dickinson and Company has experienced noticeable shifts in its key financial metrics. Revenue grew from US$17,117 million in 2020 to US$20,248 million in 2021—a roughly 18% increase—indicating strong market performance and possibly favorable demand conditions. However, revenue dipped to US$18,870 million in 2022 before rebounding to US$19,372 million in 2023 and reaching US$20,178 million in 2024, suggesting some year-over-year volatility. Gross profit followed a similar trend, rising by approximately 24% from US$7,577 million in 2020 to US$9,427 million in 2021, then declining by around 10% to US$8,477 million in 2022 and further to US$8,170 million in 2023, before recovering to US$9,125 million in 2024. Operating income nearly doubled in 2021 (from US$1,484 million to US$2,799 million), marking a significant swing of over 80%, but then dropped by about 18% in 2022 and saw a modest decline the following year, before eventually increasing to US$2,397 million in 2024. Net income displayed sharp dynamics as well, leaping from US$874 million in 2020 to US$2,092 million in 2021—an increase of over 138%—then decreasing by roughly 15% in 2022 and further by approximately 17% in 2023 before recovering to US$1,705 million in 2024. This volatility could be driven by a combination of shifting market conditions, competitive pressures in the medical technology sector, and changing operational efficiencies. Becton, Dickinson and Company operates in an environment that values innovation and stringent regulatory compliance, which likely contributed to the strong 2021 performance. Overall, despite the fluctuations observed, the company’s revenue base, gross margins, and operating performance suggest a resilient financial foundation, positioning it well to adapt to evolving market conditions and sustain its long-term profitability.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.